Clustering data with hclust algorithm for Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of serum samples (Study ST000082)

ESI/QTOF negative ion mode (Analysis AN000134)
MetaboliteStructureF1F2
FA (20:4)ME6563332.000.95
PI (34:2)ME6563911.110.99
plasmenyl-PE (36:4)ME6564171.120.99
plasmenyl-PC (36:1)ME6564051.091.00
plasmenyl-PC (34:1)ME6564021.071.00
plasmenyl-PC (34:2)ME6564031.081.00
LPC (16:0)ME6563411.180.99
PC (36:4) AME6563641.210.99
FA (18:2)ME6563321.230.99
PI (36:3)ME6563941.220.99
plasmenyl-PE (36:5)ME6564180.421.03
SM (d43:2)ME6564480.431.03
Cer (d39:1)ME6563250.461.03
FA (18:1)ME6563310.451.03
Cer (d36:1)ME6563230.441.03
PE (34:1) BME6563770.441.03
Cer (d38:1)ME6563240.481.03
PE (38:1) AME6563830.481.03
Cer (d34:1)ME6563210.501.03
PE (36:4) BME6563820.501.03
LPE (22:6)ME6563490.491.03
SM (d32:1)ME6564280.491.03
PC (30:0)ME6563500.541.02
PC (36:1)ME6563610.541.02
PC (34:1)ME6563570.531.02
PE (38:4) BME6563840.531.02
PI (32:1)ME6563890.511.03
PI (40:6)ME6563990.521.02
PC (34:4)ME6563590.521.02
PC (40:6)ME6563750.521.02
FA (16:1)ME6563300.201.04
PC (36:5)ME6563660.291.04
PE (38:6) BME6563850.281.04
Cer (d42:2)ME6563290.381.03
PC (33:1)ME6563540.391.03
Cer (d32:1)ME6563190.341.03
PC (32:1)ME6563520.361.03
PC (33:2)ME6563550.631.02
SM (d42:2)ME6564460.631.02
GlcCer (d38:1)ME6563350.601.02
PC (38:5)ME6563710.601.02
Cer (d34:2)ME6563220.621.02
PC (32:2)ME6563530.621.02
Cer (d41:1)ME6563280.611.02
Cer (d40:1)ME6563260.611.02
Cer (d40:2)ME6563270.611.02
Cer (d34:0)ME6563200.581.02
SM (d33:1)ME6564300.581.02
PE 38:5ME6563880.551.02
GlcCer (d34:1)ME6563340.561.02
SM (d36:0)ME6564340.561.02
PI (38:3)ME6563960.731.01
PE (36:2) BME6563800.731.01
PC (38:3)ME6563690.731.01
LPE (18:2)ME6563470.731.01
PC (34:0)ME6563560.731.01
PC (36:4) BME6563650.721.01
PE (44:3) AME6563870.721.01
PI (36:1)ME6563920.751.01
plasmenyl-PC (42:4)ME6564120.741.01
SM (d32:2)ME6564290.741.01
plasmenyl-PE (40:6)ME6564250.711.01
SM (d38:1)ME6564370.701.02
SM (d36:1)ME6564350.701.02
PE (40:4) AME6563860.701.02
plasmenyl-PE (38:6)ME6564220.701.02
PI (34:1)ME6563900.651.02
LPE (20:4)ME6563480.651.02
PC (40:5)ME6563740.651.02
plasmenyl-PE (40:7)ME6564260.681.02
plasmenyl-PC (40:4)ME6564110.681.02
GlcCer (d41:1)ME6563370.681.02
PC (36:3)ME6563630.681.02
plasmenyl-PC (38:4)ME6564090.691.02
LPC (14:0)ME6563400.691.02
LPC (16:1)ME6563420.691.02
plasmenyl-PE (36:1)ME6564150.671.02
plasmenyl-PC (34:0)ME6564010.671.02
PI (38:4)ME6563970.671.02
GlcCer (d42:2)ME6563390.671.02
PC (32:0)ME6563510.671.02
PI (36:4)ME6563950.661.02
plasmenyl-PE (34:1)ME6564130.661.02
GlcCer (d42:1)ME6563380.851.01
PE (36:3) BME6563810.851.01
SM (d40:0)ME6564390.841.01
plasmenyl-PE (40:5)ME6564240.841.01
PC (34:2)ME6563580.841.01
LPC (20:3)ME6563450.841.01
LPE (16:0)ME6563460.841.01
SM (d36:2)ME6564360.881.01
LPC (18:1)ME6563430.861.01
GlcCer (d40:1)ME6563360.871.01
plasmenyl-PC (38:5)ME6564100.871.01
plasmenyl-PC (38:0)ME6564080.781.01
SM (d34:1)ME6564320.781.01
PE (34:2) BME6563780.771.01
plasmenyl-PC (36:3)ME6564060.761.01
SM (d42:3)ME6564470.811.01
SM (d41:1)ME6564430.811.01
SM (d34:0)ME6564310.811.01
plasmenyl-PC (36:0)ME6564040.811.01
PC (35:2)ME6563600.811.01
PC (40:8)ME6563760.811.01
plasmenyl-PE (34:2)ME6564140.821.01
PC (38:4)ME6563700.821.01
PI (38:5)ME6563980.821.01
SM (d41:2)ME6564440.801.01
PC (38:2)ME6563680.801.01
PE (36:2) AME6563790.801.01
plasmenyl-PC (32:0)ME6564000.791.01
SM (d34:2)ME6564330.791.01
plasmenyl-PC (36:4)ME6564070.941.00
SM (d42:1)ME6564450.931.00
plasmenyl-PE (36:2)ME6564160.931.00
plasmenyl-PE (40:4)ME6564230.931.00
PC (36:2)ME6563620.911.00
PC (37:4)ME6563670.901.01
SM (d40:1)ME6564400.901.01
SM (d38:2)ME6564380.961.00
PC (40:4)ME6563730.981.00
plasmenyl-PE (38:4)ME6564200.981.00
PS (p34:0)ME6564270.971.00
PI (36:2)ME6563930.971.00
plasmenyl-PE (38:5)ME6564210.971.00
PC (38:6)ME6563721.041.00
LPC (18:2)ME6563441.001.00
SM (d40:2)ME6564411.001.00
plasmenyl-PE (38:3)ME6564191.021.00
SM (d40:3)ME6564421.021.00

Factors:

F1Source:Pooled Plasma
F2Source:Serum
Data matrix
  logo